A more national process is needed to decide whether the National Health Service will fund drugs that have not been approved, or not yet approved, for routine NHS use, says Macmillan Cancer Support, the charity.

At the moment, patients can appeal for exceptional funding by their local primary care trust when a drug has not been approved by the National Institute for Clinical Excellence, or not yet approved.